Lilly to launch Mounjaro pen in India to compete with Novo’s Wegovy

Eli Lilly announced that India’s drug regulator has approved its Mounjaro KwikPen, a pre-filled injector pen for weight loss and diabetes treatment. Previously available only in vials, Mounjaro will now be offered in six dose strengths, enhancing convenience and competitiveness against Novo Nordisk’s newly launched Wegovy, which also features a user-friendly pen format.